Active Not RecruitingNCT04733534
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
PHASE2 · 120 planned enrolment
- Countries listed
- 1
- Registry update
- September 30, 2026
immortal.lifeTrial registrations containing the exact intervention label Fisetin.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 120 planned enrolment
PHASE2 · 164 planned enrolment
PHASE2 · 40 planned enrolment
Phase not reported · 120 planned enrolment
PHASE2 · 40 planned enrolment
PHASE2 · 34 planned enrolment
PHASE2 · 20 planned enrolment
PHASE1 · PHASE2 · 75 planned enrolment
PHASE2 · 74 planned enrolment
PHASE1 · PHASE2 · 68 planned enrolment
PHASE1 · PHASE2 · 100 planned enrolment